Low-cost, rapidly-developed, 3D printed in vitro corpus callosum model for mucopolysaccharidosis type I
The rising prevalence of high throughput screening and the general inability of (1) two dimensional (2D) cell culture and (2) in vitro release studies to predict in vivo neurobiological and pharmacokinetic responses in humans has led to greater interest in more realistic three dimensional (3D) bench...
Saved in:
Published in | F1000 research Vol. 5; p. 2811 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
F1000 Research Ltd
2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The rising prevalence of high throughput screening and the general inability of (1) two dimensional (2D) cell culture and (2)
in vitro
release studies to predict
in vivo
neurobiological and pharmacokinetic responses in humans has led to greater interest in more realistic three dimensional (3D) benchtop platforms. Advantages of 3D human cell culture over its 2D analogue, or even animal models, include taking the effects of microgeometry and long-range topological features into consideration. In the era of personalized medicine, it has become increasingly valuable to screen candidate molecules and synergistic therapeutics at a patient-specific level, in particular for diseases that manifest in highly variable ways. The lack of established standards and the relatively arbitrary choice of probing conditions has limited
in vitro
drug release to a largely qualitative assessment as opposed to a predictive, quantitative measure of pharmacokinetics and pharmacodynamics in tissue. Here we report the methods used in the rapid, low-cost development of a 3D model of a mucopolysaccharidosis type I patient’s corpus callosum, which may be used for cell culture and drug release. The CAD model is developed from
in vivo
brain MRI tracing of the corpus callosum using open-source software, printed with poly (lactic-acid) on a Makerbot Replicator 5X, UV-sterilized, and coated with poly (lysine) for cellular adhesion. Adaptations of material and 3D printer for expanded applications are also discussed. |
---|---|
ISSN: | 2046-1402 2046-1402 |
DOI: | 10.12688/f1000research.9861.1 |